Why KPRX? Kiora Pharmaceuticals, Inc. Analysis, Price & AI Insights | Whystock
KPRX
$2.44+0.09 (+3.83%)
Market ClosedLast close May 1
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.